Literature DB >> 10995205

General method to label antisense oligonucleotides with radioactive halogens for pharmacological and imaging studies.

B Kühnast1, F Dollé, S Terrazzino, B Rousseau, C Loc'h, F Vaufrey, F Hinnen, I Doignon, F Pillon, C David, C Crouzel, B Tavitian.   

Abstract

Evaluation of oligonucleotides for biomedical applications requires different in vivo and in vitro approaches (pharmacokinetics, biodistribution, macro- and microimaging, metabolism,.), that are performed with different radioisotopes according to the temporal and spatial resolution needed. A method to introduce radioactive isotopes of halogens (fluorine, bromine, and iodine) in a small and stable molecule has been developed. Radiosynthons can then be conjugated with any given oligonucleotide in one step to create the appropriate radiotracer. This general radiolabeling procedure for oligonucleotides is efficient to synthesize (18)F-, (76)Br-, and (125)I-oligonucleotides for biological needs. Applications of the method to biodistribution, metabolism, in vivo and ex vivo imaging of (125)I- and (18)F-labeled oligonucleotides are reported.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10995205     DOI: 10.1021/bc990183i

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  12 in total

1.  Aptamares: a novel class of radiopharmaceutical with diagnostic and therapeutic potential.

Authors:  S Guhlke; M Famulok; H J Biersack
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-11       Impact factor: 9.236

2.  In vivo biodistribution and pharmacokinetics of 18F-labelled Spiegelmers: a new class of oligonucleotidic radiopharmaceuticals.

Authors:  Raphaël Boisgard; Bertrand Kuhnast; Stefan Vonhoff; Chéraz Younes; Françoise Hinnen; Jean-Marc Verbavatz; Bernard Rousseau; Jens Peter Fürste; Britta Wlotzka; Frédéric Dollé; Sven Klussmann; Bertrand Tavitian
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-12-22       Impact factor: 9.236

3.  Radiolabeled oligonucleotides for antisense imaging.

Authors:  Arun K Iyer; Jiang He
Journal:  Curr Org Synth       Date:  2011-08-01       Impact factor: 1.975

Review 4.  18 F-Labeling of Sensitive Biomolecules for Positron Emission Tomography.

Authors:  Hema S Krishnan; Longle Ma; Neil Vasdev; Steven H Liang
Journal:  Chemistry       Date:  2017-09-01       Impact factor: 5.236

5.  In vitro characterization of two novel biodegradable vectors for the delivery of radiolabeled antisense oligonucleotides.

Authors:  Elisabeth von Guggenberg; Soraya Shahhosseini; Ingrid Koslowsky; Afsaneh Lavasanifar; David Murray; John Mercer
Journal:  Cancer Biother Radiopharm       Date:  2010-12       Impact factor: 3.099

6.  Application of locked nucleic acids to improve aptamer in vivo stability and targeting function.

Authors:  Kathrin S Schmidt; Sandra Borkowski; Jens Kurreck; Andrew W Stephens; Rolf Bald; Maren Hecht; Matthias Friebe; Ludger Dinkelborg; Volker A Erdmann
Journal:  Nucleic Acids Res       Date:  2004-10-27       Impact factor: 16.971

7.  Synthesis and preliminary evaluation of [18F]-labeled 2-oxoquinoline derivatives for PET imaging of cannabinoid CB2 receptor.

Authors:  Nashaat Turkman; Aleksander Shavrin; Vincenzo Paolillo; Hsin Hsien Yeh; Leo Flores; Suren Soghomonian; Brian Rabinovich; Andrei Volgin; Juri Gelovani; Mian Alauddin
Journal:  Nucl Med Biol       Date:  2012-01-04       Impact factor: 2.408

Review 8.  In vivo imaging with oligonucleotides for diagnosis and drug development.

Authors:  B Tavitian
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

9.  In vivo imaging of pyrrole-imidazole polyamides with positron emission tomography.

Authors:  Daniel A Harki; Nagichettiar Satyamurthy; David B Stout; Michael E Phelps; Peter B Dervan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-27       Impact factor: 11.205

10.  Automated synthesis of an 18F-labelled pyridine-based alkylating agent for high yield oligonucleotide conjugation.

Authors:  Elisabeth von Guggenberg; Jayden A Sader; John S Wilson; Soraya Shahhosseini; Ingrid Koslowsky; Frank Wuest; John R Mercer
Journal:  Appl Radiat Isot       Date:  2009-04-19       Impact factor: 1.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.